Suppr超能文献

采用固定化青霉素 G 酰化酶生产头孢克洛中残留蛋白的综合策略。

Integrative strategy to determine residual proteins in cefaclor produced by immobilized penicillin G acylase.

机构信息

Department of Antibiotics, National Institutes for Food and Drug Control, Beijing 102629, China.

School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, China.

出版信息

J Pharm Biomed Anal. 2020 Jun 5;185:113229. doi: 10.1016/j.jpba.2020.113229. Epub 2020 Mar 4.

Abstract

There is a growing trend in the pharmaceutical industry towards substituting conventional chemical synthesis routes of semi-synthetic β-lactam antibiotics (SSBAs) through environmentally sustainable enzymatic processes. These have advantages such as cost reduction in terms of solvent and waste treatment and time saving owing to fewer reaction steps. Penicillin G acylase (PGA) is an industrially important enzyme that is mainly used to catalyze the synthesis of SSBAs. In this study, we established an integrative strategy using three different analytical methods for determining the PGA-associated residual protein content, which is a critical quality issue in the end product. Cefaclor was taken as representative example of SSBAs. High-performance liquid chromatography coupled with fluorescence detection (HPLC-FD) allowed the routine analysis of PGA residual proteins and other low molecular weight (MW) impurities with high detection specificity and sensitivity, comparable to those of the Bradford assay and microfluidic protein chip electrophoresis. However, these latter two methods were superior for quantitative and qualitative analysis, respectively, and should be regarded as necessary adjuncts to the HPLC-FD method. By combining the three methods, trace levels of residual proteins were detected in four (out of 13) cefaclor bulk samples from two different manufacturers, with a major protein MW of ∼63 kDa. This suggests that the higher MW PGA subunit tends to persist in the end product. The integrative determination strategy described here can be used to evaluate SSBA bulk samples and monitor the process of SSBA manufacturing by enzymatic methods, especially in terms of inter-batch consistency and process stability.

摘要

在制药行业,越来越倾向于用环境可持续的酶法工艺替代半合成β-内酰胺抗生素(SSBAs)的传统化学合成路线。这些方法具有减少溶剂和废物处理成本以及因反应步骤较少而节省时间等优势。青霉素 G 酰化酶(PGA)是一种具有工业重要性的酶,主要用于催化 SSBAs 的合成。在这项研究中,我们建立了一种整合策略,使用三种不同的分析方法来确定 PGA 相关的残留蛋白含量,这是最终产品的一个关键质量问题。头孢克洛被选为 SSBAs 的代表性例子。高效液相色谱法结合荧光检测(HPLC-FD)允许常规分析 PGA 残留蛋白和其他低分子量(MW)杂质,具有高检测特异性和灵敏度,可与 Bradford 测定法和微流控蛋白芯片电泳相媲美。然而,后两种方法在定量和定性分析方面更具优势,应被视为 HPLC-FD 方法的必要补充。通过结合这三种方法,我们在来自两个不同制造商的 13 个头孢克洛散装样品中的 4 个(占 4 个)中检测到痕量残留蛋白,主要蛋白 MW 约为 63 kDa。这表明较高 MW 的 PGA 亚基在最终产物中更倾向于存在。这里描述的综合测定策略可用于评估 SSBA 散装样品,并通过酶法监测 SSBA 制造过程,特别是在批次间一致性和过程稳定性方面。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验